TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 118,864 | 90,862 | 74,331 |
Financial expenses | 110 | 3 | 7 |
Earnings before taxes | 63,894 | 60,352 | 47,209 |
EBITDA | 63,562 | 60,344 | 47,212 |
Total assets | 82,458 | 56,427 | 60,388 |
Current assets | 81,129 | 49,029 | 53,420 |
Current liabilities | 11,963 | 6,596 | 6,711 |
Equity capital | 69,524 | 49,243 | 53,508 |
- share capital | 926 | 1,007 | 1,026 |
Employees (average) | 46 | 29 | 29 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.3% | 87.3% | 88.6% |
Turnover per employee | 2,584 | 3,133 | 2,563 |
Profit as a percentage of turnover | 53.8% | 66.4% | 63.5% |
Return on assets (ROA) | 77.6% | 107.0% | 78.2% |
Current ratio | 678.2% | 743.3% | 796.0% |
Return on equity (ROE) | 91.9% | 122.6% | 88.2% |
Change turnover | 35,362 | 17,908 | 5,550 |
Change turnover % | 42% | 25% | 8% |
Chg. No. of employees | 17 | 0 | 1 |
Chg. No. of employees % | 59% | 0% | 4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.